India, Feb. 4 -- In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners on Monday launched a first-ever vaccine trial for Ebola from the Sudan species of the virus.

The principal investigators from Makerere University and the Uganda Virus Research Institute (UVRI), with support from WHO and other partners, have worked tirelessly to get the trial ready in 4 days since the outbreak was confirmed on 30 January.

It is the first trial to assess the clinical efficacy of a vaccine against Ebola disease due to Sudan virus.

The speed was achieved through advanced research preparedness while ensuring full compliance with national and international regulatory and ethical requirements.

"This is a cr...